Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.

AUTOR(ES)

Axelrod, J H

RESUMO

Primary skin fibroblasts from hemophilic dogs were transduced by recombinant retrovirus (LNCdF9L) containing a canine factor IX cDNA. High levels of biologically active canine factor IX (1.0 micrograms per 10(6) cells per 24 hr) were secreted in the medium. The level of factor IX produced increased substantially if the cells were stimulated by basic fibroblast growth factor during infection. Additionally, we also report that endothelial cells transduced by this virus can produce high levels of biologically active factor IX. We propose that skin fibroblasts and endothelial cells from hemophilia B dogs may serve as potential venues for the development and testing of models for treatment of hemophilia B by retrovirally mediated gene replacement therapy.

Documentos Relacionados

• In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.
• Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro
• Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.
• Tuberculin-specific transfer factor in dogs.
• Mast cell chymase potentiates histamine-induced wheal formation in the skin of ragweed-allergic dogs.